Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ADD2 ADDB ENSG00000075340 Adducin 2 (beta) 2 70607618-70768225 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009796, HPA034509, HPA034510 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 10 bone marrow: 40.3;cerebral cortex: 44.8 testis: 4.1 ADGRV1 DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1 ENSG00000164199 Adhesion G protein-coupled receptor V1 5 90529344-91164221 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067503 Approved Group enriched 6 adrenal gland: 56.5;cerebral cortex: 29.1 thyroid gland: 6.6 ASTN1 ASTN ENSG00000152092 Astrotactin 1 1 176857302-177164973 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA074112 Approved Golgi apparatus
Vesicles Group enriched 6 adrenal gland: 19.7;cerebral cortex: 67.0 ovary: 7.4 ATP2B3 CFAP39, CLA2, PMCA3, SCAX1 ENSG00000067842 ATPase, Ca++ transporting, plasma membrane 3 X 153517676-153582939 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001583 Supported Uncertain Golgi apparatus
Plasma membrane Group enriched 8 adrenal gland: 12.2;cerebral cortex: 19.1 fallopian tube: 2.0 BRINP2 DBCCR1L2, FAM5B ENSG00000198797 Bone morphogenetic protein/retinoic acid inducible neural-specific 2 1 177171497-177282422 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA050681, HPA061920 Uncertain Approved Nucleoli
Vesicles Group enriched 9 adrenal gland: 11.5;cerebral cortex: 35.5 testis: 2.4 CADPS CAPS, CAPS1, KIAA1121 ENSG00000163618 Ca++-dependent secretion activator 3 62398346-62875389 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059328 Supported Approved Vesicles Group enriched 7 adrenal gland: 21.7;cerebral cortex: 94.3 heart muscle: 8.4 CALN1 ENSG00000183166 Calneuron 1 7 71779491-72447151 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036278, HPA036708 Approved Uncertain Vesicles
Plasma membrane Group enriched 5 adrenal gland: 14.8;cerebral cortex: 46.5 testis: 6.0 CALY CALCYON, DRD1IP, NSG3 ENSG00000130643 Calcyon neuron-specific vesicular protein 10 133324072-133336935 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042283 Uncertain Group enriched 13 adrenal gland: 23.6;cerebral cortex: 77.3 testis: 3.8 CELF3 BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4 ENSG00000159409 CUGBP, Elav-like family member 3 1 151702404-151716814 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006292 Uncertain Approved Nucleoplasm Group enriched 6 adrenal gland: 15.3;cerebral cortex: 51.8 stomach: 5.6 DNER bet, UNQ26 ENSG00000187957 Delta/notch-like EGF repeat containing 2 229357629-229714558 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017320 Approved Group enriched 7 adrenal gland: 74.9;cerebral cortex: 176.5 salivary gland: 17.4 DPP10 DPRP3 ENSG00000175497 Dipeptidyl-peptidase 10 (non-functional) 2 114442299-115845752 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048767 Uncertain Approved Nucleus
Vesicles
Cytosol Group enriched 7 adrenal gland: 14.2;cerebral cortex: 34.8 pancreas: 3.6 FABP7 B-FABP, BLBP ENSG00000164434 Fatty acid binding protein 7, brain 6 122779475-122784074 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025488, HPA028825, CAB058697 Supported Supported Nucleoplasm
Cytosol Group enriched 13 breast: 32.9;cerebral cortex: 102.5 skin: 5.2 FNDC9 C5orf40, MGC27121 ENSG00000172568 Fibronectin type III domain containing 9 5 157341600-157345721 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA011115, HPA017291 Approved Group enriched 17 adrenal gland: 6.3;cerebral cortex: 20.7 appendix: 0.7 FSTL5 DKFZp566D234, KIAA1263 ENSG00000168843 Follistatin-like 5 4 161383897-162164035 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045909, HPA046724 Uncertain Group enriched 10 adrenal gland: 7.8;cerebral cortex: 16.3 testis: 1.1 GALNT13 GalNAc-T13, KIAA1918 ENSG00000144278 Polypeptide N-acetylgalactosaminyltransferase 13 2 153871913-154453849 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060775 Approved Group enriched 6 adrenal gland: 6.6;cerebral cortex: 32.8 lung: 3.2 GJD2 CX36, GJA9 ENSG00000159248 Gap junction protein, delta 2, 36kDa 15 34751032-34754965 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014355 Uncertain Group enriched 6 adrenal gland: 8.0;cerebral cortex: 1.9 pancreas: 0.8 GLRA3 ENSG00000145451 Glycine receptor, alpha 3 4 174636914-174829314 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 breast: 2.6;cerebral cortex: 9.1 adrenal gland: 1.0 HBQ1 HBQ ENSG00000086506 Hemoglobin, theta 1 16 180453-181181 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062473 Supported Approved Lipid droplets Group enriched 8 bone marrow: 14.7;cerebral cortex: 3.0 placenta: 1.1 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, two pore domain subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 adrenal gland: 4.8;cerebral cortex: 4.8 cervix: 0.7 KCNMB4 ENSG00000135643 Potassium channel subfamily M regulatory beta subunit 4 12 70366276-70434292 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072287 Approved Cytosol Group enriched 8 adrenal gland: 19.6;cerebral cortex: 38.2 placenta: 3.7 LUZP2 ENSG00000187398 Leucine zipper protein 2 11 24496970-25082631 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039007, HPA046161 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 6 adrenal gland: 8.5;cerebral cortex: 33.1 prostate: 3.3 MYT1 MTF1, MYTI, NZF2, PLPB1, ZC2HC4A ENSG00000196132 Myelin transcription factor 1 20 64151791-64242253 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006303 Uncertain Supported Nucleoplasm
Cytosol Group enriched 7 adrenal gland: 2.5;cerebral cortex: 5.7 testis: 0.6 NXPH1 ENSG00000122584 Neurexophilin 1 7 8433955-8752963 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA020062 Uncertain Group enriched 83 adrenal gland: 52.3;cerebral cortex: 47.3 breast: 0.5 PNMAL2 KIAA1183 ENSG00000204851 Paraneoplastic Ma antigen family-like 2 19 46486906-46496498 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054810 Approved Group enriched 5 adrenal gland: 12.2;cerebral cortex: 33.0 ovary: 4.3 RAB3C ENSG00000152932 RAB3C, member RAS oncogene family 5 58582221-58859394 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA003160, HPA048156 Supported Approved Cytosol Group enriched 16 adrenal gland: 12.1;cerebral cortex: 55.5 small intestine: 2.0 S100B S100beta ENSG00000160307 S100 calcium binding protein B 21 46598962-46605208 Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000073, HPA015768, CAB078196 Supported Approved Nucleus
Vesicles Group enriched 9 adipose tissue: 208.2;cerebral cortex: 628.0 seminal vesicle: 49.1 SCG2 CHGC, SgII, SN ENSG00000171951 Secretogranin II 2 223596940-223602503 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002519, HPA011893 Approved Supported Group enriched 7 adrenal gland: 449.0;cerebral cortex: 232.7 duodenum: 46.3 SLC7A10 asc-1 ENSG00000130876 Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19 33208664-33225850 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041884, HPA057036 Uncertain Uncertain Nucleus
Nucleoli Group enriched 23 adipose tissue: 31.5;cerebral cortex: 6.6 breast: 0.8 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supported Group enriched 5 bone marrow: 161.2;cerebral cortex: 460.5 endometrium: 56.7 TMEM179 C14orf90, FLJ42486, TMEM179A ENSG00000258986 Transmembrane protein 179 14 104474678-104605647 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA002942 Uncertain Mitochondria Group enriched 8 adrenal gland: 14.7;cerebral cortex: 28.0 testis: 2.5 UNC5A KIAA1976, UNC5H1 ENSG00000113763 Unc-5 netrin receptor A 5 176810477-176880895 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071450 Approved Plasma membrane
Cytosol Group enriched 22 adrenal gland: 10.4;cerebral cortex: 35.5 lymph node: 1.0 VAT1L KIAA1576 ENSG00000171724 Vesicle amine transport 1-like 16 77788530-77980107 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044061, CAB046032 Approved Approved Cytosol Group enriched 6 adrenal gland: 91.0;cerebral cortex: 38.9 heart muscle: 10.6 ABCG4 WHITE2 ENSG00000172350 ATP-binding cassette, sub-family G (WHITE), member 4 11 119149012-119162653 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040312 Uncertain Group enriched 6 cerebral cortex: 6.6;parathyroid gland: 4.0;testis: 5.1 seminal vesicle: 0.8 ACSL6 ACS2, FACL6, KIAA0837, LACS2, LACS5 ENSG00000164398 Acyl-CoA synthetase long-chain family member 6 5 131949973-132012243 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040470 Uncertain Group enriched 6 bone marrow: 18.0;cerebral cortex: 62.1;parathyroid gland: 22.1;seminal vesicle: 28.7;testis: 51.2 adrenal gland: 6.5 ADAM23 MDC3 ENSG00000114948 ADAM metallopeptidase domain 23 2 206443539-206621130 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012130, CAB033276 Uncertain Group enriched 6 cerebral cortex: 55.7;parathyroid gland: 132.9 heart muscle: 16.4 ADCY8 AC8, ADCY3, HBAC1 ENSG00000155897 Adenylate cyclase 8 (brain) 8 130780301-131042426 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018652, HPA024291 Supported Group enriched 8 cerebral cortex: 12.9;epididymis: 27.3;fallopian tube: 6.2 seminal vesicle: 1.9 ANO4 FLJ34221, FLJ34272, FLJ35277, TMEM16D ENSG00000151572 Anoctamin 4 12 100717526-101128641 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053412 Uncertain Group enriched 6 adrenal gland: 17.6;cerebral cortex: 10.0;cervix, uterine: 12.5;endometrium: 8.3;ovary: 10.9;prostate: 10.9;seminal vesicle: 11.3 testis: 2.0 ANOS1 ADMLX, KAL, KAL1, KALIG-1, WFDC19 ENSG00000011201 Anosmin 1 X 8528874-8732187 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 cerebral cortex: 32.5;lung: 66.1;parathyroid gland: 47.6;thyroid gland: 15.7 testis: 7.4 AP3B2 NAPTB ENSG00000103723 Adaptor-related protein complex 3, beta 2 subunit 15 82659281-82709914 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039467, HPA039818 Supported Uncertain Nucleoplasm
Golgi apparatus
Cytosol Group enriched 6 cerebral cortex: 36.3;parathyroid gland: 7.5 adrenal gland: 3.8 APLNR AGTRL1, APJ, APJR, FLJ90771 ENSG00000134817 Apelin receptor 11 57233577-57237314 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025842 Approved Group enriched 5 cerebral cortex: 82.9;placenta: 145.6;spleen: 164.2 adipose tissue: 24.9 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supported Supported Supported Plasma membrane
Cell Junctions Group enriched 17 cerebral cortex: 631.8;lung: 172.2 thyroid gland: 24.3 ARC Arg3.1, KIAA0278 ENSG00000198576 Activity-regulated cytoskeleton-associated protein 8 142611044-142614472 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056430 Approved Vesicles
Microtubules Group enriched 7 adipose tissue: 14.1;adrenal gland: 13.4;cerebral cortex: 14.4;gallbladder: 3.3;seminal vesicle: 5.5 placenta: 1.4 ARSF ENSG00000062096 Arylsulfatase F X 3041471-3112726 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000549 Uncertain Cytosol Group enriched 6 adrenal gland: 4.0;cerebral cortex: 2.1;epididymis: 2.1;esophagus: 2.3;kidney: 8.0;skin: 6.7 urinary bladder: 0.6 ASCL1 ASH1, bHLHa46, HASH1 ENSG00000139352 Achaete-scute family bHLH transcription factor 1 12 102957686-102960516 Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029217 Supported Group enriched 8 cerebral cortex: 16.3;liver: 6.5 adrenal gland: 1.4 ASIC2 ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG ENSG00000108684 Acid sensing (proton gated) ion channel 2 17 33013087-34174964 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052112 Approved Group enriched 6 cerebral cortex: 8.7;cervix, uterine: 3.9;endometrium: 6.4;smooth muscle: 2.1 adrenal gland: 0.8 ASPDH ENSG00000204653 Aspartate dehydrogenase domain containing 19 50511600-50514690 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042631, HPA042654 Approved Group enriched 7 cerebral cortex: 17.9;duodenum: 7.1;kidney: 27.9;liver: 34.6 adrenal gland: 3.3 ATP1A2 FHM2, MHP2 ENSG00000018625 ATPase, Na+/K+ transporting, alpha 2 polypeptide 1 160115759-160143591 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022230 Approved Group enriched 6 cerebral cortex: 435.6;skeletal muscle: 307.1 heart muscle: 59.1 ATP8A2 ATPIB, ML-1 ENSG00000132932 ATPase, aminophospholipid transporter, class I, type 8A, member 2 13 25372071-26025851 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039926, HPA040033 Approved Supported Nucleoplasm
Plasma membrane Group enriched 6 cerebral cortex: 26.5;testis: 10.6 adrenal gland: 2.9 BIN1 AMPH2, AMPHL, SH3P9 ENSG00000136717 Bridging integrator 1 2 127048027-127107355 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001945, HPA003894, HPA005437 Supported Supported Cytosol Group enriched 7 cerebral cortex: 156.9;skeletal muscle: 724.3 adrenal gland: 61.7 C10orf90 bA422P15.2, FATS, FLJ32938 ENSG00000154493 Chromosome 10 open reading frame 90 10 126424997-126670446 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038648, HPA057599 Uncertain Uncertain Nucleoplasm
Plasma membrane
Cytosol Group enriched 13 breast: 5.6;cerebral cortex: 15.3;salivary gland: 4.4;testis: 12.4 tonsil: 0.7 C2CD4C FAM148C, KIAA1957, NLF3 ENSG00000183186 C2 calcium-dependent domain containing 4C 19 405438-409170 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055915 Uncertain Approved Vesicles Group enriched 6 adipose tissue: 2.5;cerebral cortex: 10.7;gallbladder: 4.4 endometrium: 0.9 C9orf129 bA165J3.3 ENSG00000204352 Chromosome 9 open reading frame 129 9 93318199-93346414 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA071515 Uncertain Mitochondria Group enriched 7 cerebral cortex: 4.1;testis: 1.7 epididymis: 0.4 CACNA1B CACNL1A5, CACNN, Cav2.2 ENSG00000148408 Calcium channel, voltage-dependent, N type, alpha 1B subunit 9 137877789-138124624 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044347 Uncertain Group enriched 8 adrenal gland: 3.7;cerebral cortex: 14.9;fallopian tube: 4.8;testis: 7.6 prostate: 1.0 CACNB1 CACNLB1 ENSG00000067191 Calcium channel, voltage-dependent, beta 1 subunit 17 39173456-39197703 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA023343 Approved Group enriched 6 cerebral cortex: 46.9;skeletal muscle: 108.5 skin: 12.3 CARNS1 ATPGD1, KIAA1394 ENSG00000172508 Carnosine synthase 1 11 67414968-67425607 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038569 Approved Group enriched 9 cerebral cortex: 37.2;skeletal muscle: 25.9 heart muscle: 3.4 CBLN2 ENSG00000141668 Cerebellin 2 precursor 18 72536680-72638521 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056335 Uncertain Endoplasmic reticulum Group enriched 7 cerebral cortex: 30.3;seminal vesicle: 7.2 small intestine: 2.8 CCK ENSG00000187094 Cholecystokinin 3 42257825-42266207 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002308, HPA045039 Supported Supported Group enriched 5 cerebral cortex: 134.1;duodenum: 119.6;prostate: 32.8 small intestine: 18.1 CCKBR ENSG00000110148 Cholecystokinin B receptor 11 6259736-6272127 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 14 cerebral cortex: 13.7;pancreas: 5.4;stomach: 16.1 prostate: 0.8 CDH10 ENSG00000040731 Cadherin 10, type 2 (T2-cadherin) 5 24487100-24644978 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010651 Approved Group enriched 19 cerebral cortex: 32.7;prostate: 6.8 adrenal gland: 1.0 CDH12 Br-cadherin, CDHB ENSG00000154162 Cadherin 12, type 2 (N-cadherin 2) 5 21750673-22853622 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029325 Uncertain Approved Vesicles Group enriched 5 adrenal gland: 2.5;cerebral cortex: 3.8;cervix, uterine: 5.3;fallopian tube: 4.0;skin: 1.1;testis: 2.7 breast: 0.6 CDH22 C20orf25, dJ998H6.1 ENSG00000149654 Cadherin 22, type 2 20 46173733-46308498 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA012164 Uncertain Group enriched 6 adrenal gland: 2.0;cerebral cortex: 10.3;fallopian tube: 2.3;skin: 5.2 testis: 0.8 CDH8 ENSG00000150394 Cadherin 8, type 2 16 61647242-62037035 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014908, HPA058444 Approved Supported Plasma membrane Group enriched 8 cerebral cortex: 27.9;seminal vesicle: 6.9 ovary: 2.1 CECR6 ENSG00000183307 Cat eye syndrome chromosome region, candidate 6 22 17116299-17121367 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA068790 Approved Nucleoplasm
Vesicles
Plasma membrane Group enriched 7 cerebral cortex: 15.0;prostate: 10.9 testis: 1.9 CELSR3 ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2 ENSG00000008300 Cadherin, EGF LAG seven-pass G-type receptor 3 3 48636469-48662915 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062866 Approved Group enriched 6 adrenal gland: 1.6;cerebral cortex: 6.0;testis: 3.6 parathyroid gland: 0.6 CERS1 LAG1, LASS1, UOG1 ENSG00000223802 Ceramide synthase 1 19 18868545-18896727 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045724 Approved Approved Endoplasmic reticulum Group enriched 13 cerebral cortex: 136.6;testis: 28.0 skeletal muscle: 6.5 CHN1 ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2 ENSG00000128656 Chimerin 1 2 174799363-175005369 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036111 Approved Cytosol Group enriched 7 cerebral cortex: 640.9;parathyroid gland: 131.0 placenta: 55.5 CHRM1 ENSG00000168539 Cholinergic receptor, muscarinic 1 11 62908679-62921807 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014101, CAB022366 Supported Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 40.0;prostate: 40.1;salivary gland: 11.1 breast: 4.7 CLEC2L FLJ32986 ENSG00000236279 C-type lectin domain family 2, member L 7 139523856-139544984 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence Evidence at protein level HPA045050 Supported Group enriched 9 cerebral cortex: 21.0;parathyroid gland: 13.4 endometrium: 1.9 CLVS2 bA160A10.4, C6orf212, C6orf213, RLBP1L2 ENSG00000146352 Clavesin 2 6 122995971-123072927 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043764 Uncertain Group enriched 6 cerebral cortex: 15.5;prostate: 4.4 endometrium: 1.6 CNDP1 CN1, CPGL2, HsT2308, MGC10825 ENSG00000150656 Carnosine dipeptidase 1 (metallopeptidase M20 family) 18 74534440-74587212 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008933 Supported Group enriched 12 cerebral cortex: 102.0;liver: 23.0 duodenum: 5.2 CNTNAP2 Caspr2, KIAA0868, NRXN4 ENSG00000174469 Contactin associated protein-like 2 7 146116002-148420998 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002739 Supported Group enriched 11 cerebral cortex: 20.2;prostate: 5.7 breast: 1.2 COL9A3 DJ885L7.4.1, EDM3, FLJ90759, IDD, MED ENSG00000092758 Collagen, type IX, alpha 3 20 62816244-62841159 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040125, HPA058323 Uncertain Approved Nucleoplasm
Intermediate filaments Group enriched 6 cerebral cortex: 7.5;salivary gland: 10.5;testis: 6.4;thyroid gland: 19.3 seminal vesicle: 1.8 CPNE6 ENSG00000100884 Copine VI (neuronal) 14 24070837-24078100 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031636 Approved Group enriched 6 cerebral cortex: 88.2;seminal vesicle: 34.7 kidney: 9.6 CRB1 LCA8, RP12 ENSG00000134376 Crumbs family member 1, photoreceptor morphogenesis associated 1 197268204-197478455 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA061250, HPA063127 Approved Uncertain Vesicles Group enriched 10 cerebral cortex: 12.1;testis: 4.9 ovary: 0.8 CRYM DFNA40 ENSG00000103316 Crystallin, mu 16 21238874-21303083 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019086, HPA030619 Supported Supported Cytosol Group enriched 6 cerebral cortex: 102.6;heart muscle: 98.1;kidney: 56.5;prostate: 52.7;urinary bladder: 30.8 lung: 11.5 CSMD3 ENSG00000164796 CUB and Sushi multiple domains 3 8 112222928-113437099 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029007 Uncertain Group enriched 7 cerebral cortex: 4.9;testis: 1.8 spleen: 0.4 CTNNA2 CAP-R, CT114 ENSG00000066032 Catenin (cadherin-associated protein), alpha 2 2 79185231-80648861 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB037175 Approved Group enriched 12 cerebral cortex: 111.9;epididymis: 80.2;testis: 32.0 adrenal gland: 6.4 CTXN2 ENSG00000233932 Cortexin 2 15 48191539-48203756 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA053168 Uncertain Group enriched 8 cerebral cortex: 1.9;testis: 1.5 fallopian tube: 0.2 DACH2 ENSG00000126733 Dachshund family transcription factor 2 X 86148458-86832604 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA000258 Uncertain Group enriched 8 cerebral cortex: 11.9;epididymis: 4.4;fallopian tube: 5.0 kidney: 0.8 DBX2 FLJ16139 ENSG00000185610 Developing brain homeobox 2 12 45014672-45051099 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA066053 Uncertain Group enriched 5 cerebral cortex: 4.1;testis: 1.2 skin: 0.5 DDN KIAA0749 ENSG00000181418 Dendrin 12 48995149-48999309 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060952 Uncertain Approved Nucleoplasm
Cytosol Group enriched 10 cerebral cortex: 96.3;skeletal muscle: 46.6 kidney: 6.9 DDX25 GRTH ENSG00000109832 DEAD (Asp-Glu-Ala-Asp) box helicase 25 11 125903376-125928829 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020137 Supported Group enriched 8 cerebral cortex: 10.0;testis: 22.3 fallopian tube: 2.1 DGKI DGK-IOTA ENSG00000157680 Diacylglycerol kinase, iota 7 137381037-137847092 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021924 Uncertain Approved Nucleoplasm Group enriched 10 cerebral cortex: 9.3;thyroid gland: 32.8 heart muscle: 2.0 DLGAP2 DAP-2 ENSG00000198010 Discs, large (Drosophila) homolog-associated protein 2 8 1501366-1708476 Nuclear receptors, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030320 Uncertain Group enriched 10 cerebral cortex: 1.9;testis: 5.5 kidney: 0.3 DLGAP3 DAP3, SAPAP3 ENSG00000116544 Discs, large (Drosophila) homolog-associated protein 3 1 34865436-34929585 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026445 Supported Group enriched 11 cerebral cortex: 21.9;testis: 5.7 spleen: 1.2 DNAJC18 MGC29463 ENSG00000170464 DnaJ (Hsp40) homolog, subfamily C, member 18 5 139408588-139444491 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036538, HPA060154 Approved Supported Cell Junctions Group enriched 5 cerebral cortex: 30.2;testis: 115.2 ovary: 13.8 DOC2A ENSG00000149927 Double C2-like domains, alpha 16 30005509-30023270 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065676 Uncertain Nucleus
Nucleoli
Cell Junctions Group enriched 9 cerebral cortex: 69.9;testis: 21.0 ovary: 5.2 DOCK3 KIAA0299, MOCA, PBP ENSG00000088538 Dedicator of cytokinesis 3 3 50675241-51384198 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037543, HPA037544 Approved Validated Cytosol Group enriched 6 cerebral cortex: 33.8;parathyroid gland: 12.5;testis: 8.5;thyroid gland: 15.1 adrenal gland: 3.0 DPYSL5 CRAM, CRMP-5, CRMP5, Ulip6 ENSG00000157851 Dihydropyrimidinase-like 5 2 26847747-26950351 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034544, HPA072387 Supported Approved Nucleoplasm
Cytosol Group enriched 8 cerebral cortex: 31.4;testis: 10.0 adrenal gland: 2.5 EEF1A2 EEF1AL, HS1, STN, STNL ENSG00000101210 Eukaryotic translation elongation factor 1 alpha 2 20 63488013-63499315 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034019, HPA051759, HPA053862, HPA056990 Approved Validated Nucleoli
Cytosol Group enriched 6 cerebral cortex: 410.5;heart muscle: 413.7;skeletal muscle: 1373.0 adrenal gland: 128.3 EGR4 NGFI-C, PAT133 ENSG00000135625 Early growth response 4 2 73290929-73293705 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028983 Approved Group enriched 29 cerebral cortex: 9.7;testis: 3.2 appendix: 0.2 ELAVL2 HEL-N1, HuB ENSG00000107105 ELAV like neuron-specific RNA binding protein 2 9 23690104-23826337 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022222, HPA063001 Supported Approved Nucleoplasm
Cytosol Group enriched 32 cerebral cortex: 38.1;testis: 80.2 adrenal gland: 1.8 ELAVL4 HUD, PNEM ENSG00000162374 ELAV like neuron-specific RNA binding protein 4 1 50048014-50203786 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004442 Supported Group enriched 8 adrenal gland: 10.8;cerebral cortex: 53.5;testis: 10.8 appendix: 2.9 ELMOD1 DKFZp547C176 ENSG00000110675 ELMO/CED-12 domain containing 1 11 107591091-107666779 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA038434, HPA038435 Supported Nucleoplasm
Cytosol Group enriched 15 cerebral cortex: 71.6;skin: 36.8 fallopian tube: 3.5 ETNPPL AGXT2L1 ENSG00000164089 Ethanolamine-phosphate phospho-lyase 4 108742040-108763054 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044546, HPA072938 Approved Approved Nucleus Group enriched 8 cerebral cortex: 141.6;liver: 98.5 stomach: 14.7 FAM107A DRR1, TU3A ENSG00000168309 Family with sequence similarity 107, member A 3 58564117-58627610 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055888 Approved Approved Nuclear speckles Group enriched 5 cerebral cortex: 487.1;fallopian tube: 123.9 epididymis: 56.9 FAM133A CT115, FLJ37659, RP1-32F7.2 ENSG00000179083 Family with sequence similarity 133, member A X 93674013-93712274 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066175, HPA069513 Approved Nucleus
Nucleoli Group enriched 6 cerebral cortex: 5.3;testis: 14.0 adrenal gland: 1.5 FAM135B C8ORFK32 ENSG00000147724 Family with sequence similarity 135, member B 8 138130023-138496822 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023911, HPA023950, HPA024815 Uncertain Approved Nucleoplasm
Nuclear membrane Group enriched 7 adrenal gland: 3.6;cerebral cortex: 8.3;testis: 7.2 colon: 0.8 FAM181A C14orf152 ENSG00000140067 Family with sequence similarity 181, member A 14 93918894-93929608 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA001603 Supported Group enriched 5 cerebral cortex: 3.4;fallopian tube: 3.2;testis: 13.9 thyroid gland: 1.3 FAM216A C12orf24, HSU79274 ENSG00000204856 Family with sequence similarity 216, member A 12 110468364-110490385 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038286 Approved Approved Actin filaments Group enriched 7 cerebral cortex: 16.2;testis: 60.9 appendix: 5.7 FAM57B DKFZP434I2117 ENSG00000149926 Family with sequence similarity 57, member B 16 30024427-30052978 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030837 Uncertain Group enriched 12 cerebral cortex: 18.7;testis: 77.3 skeletal muscle: 3.9 FMN2 ENSG00000155816 Formin 2 1 240014348-240475189 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050649 Approved Plasma membrane
Actin filaments Group enriched 6 cerebral cortex: 54.0;parathyroid gland: 32.9 adrenal gland: 7.0 FRMD5 MGC14161 ENSG00000171877 FERM domain containing 5 15 43870761-44195252 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011746, HPA013961 Uncertain Uncertain Golgi apparatus
Centrosome Group enriched 6 adrenal gland: 7.1;cerebral cortex: 20.1;heart muscle: 7.1;testis: 5.5 fallopian tube: 1.6 FRMPD2 MGC35285, PDZD5C, PDZK5C ENSG00000170324 FERM and PDZ domain containing 2 10 48156558-48274870 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045059 Uncertain Group enriched 6 cerebral cortex: 3.9;fallopian tube: 5.3;testis: 2.9 thyroid gland: 0.7 FRMPD4 KIAA0316, PDZD10, PDZK10 ENSG00000169933 FERM and PDZ domain containing 4 X 12138466-12724523 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035580 Uncertain Group enriched 32 cerebral cortex: 15.5;parathyroid gland: 23.8 heart muscle: 0.6 FSD1 MGC3213, MIR1 ENSG00000105255 Fibronectin type III and SPRY domain containing 1 19 4304600-4323843 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043141 Supported Group enriched 12 cerebral cortex: 25.5;testis: 9.1 lymph node: 1.4 FUT9 Fuc-TIX ENSG00000172461 Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) 6 96015984-96215612 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA070923 Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Cytosol Group enriched 12 cerebral cortex: 28.2;stomach: 22.2 duodenum: 2.1 GALNT8 GALNAC-T8 ENSG00000130035 Polypeptide N-acetylgalactosaminyltransferase 8 12 4720341-4851927 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA012638, HPA014418, HPA073461 Approved Approved Vesicles Group enriched 7 cerebral cortex: 19.5;colon: 18.0;duodenum: 8.4;rectum: 41.3;small intestine: 19.3;testis: 26.3 appendix: 3.3 GALNT9 GALNAC-T9 ENSG00000182870 Polypeptide N-acetylgalactosaminyltransferase 9 12 132196372-132329349 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA075016 Approved Vesicles Group enriched 7 cerebral cortex: 29.5;epididymis: 7.8;thyroid gland: 6.4 kidney: 1.9 GAREML FAM59B, FLJ00375, KIAA2038 ENSG00000157833 GRB2 associated, regulator of MAPK1-like 2 26173091-26189663 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA071575 Approved Cytosol Group enriched 6 cerebral cortex: 23.1;parathyroid gland: 17.5 smooth muscle: 3.4 GJB6 CX30, DFNA3, ED2, EDH, HED ENSG00000121742 Gap junction protein, beta 6, 30kDa 13 20221971-20232395 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014846 Supported Cell Junctions Group enriched 5 bone marrow: 47.6;cerebral cortex: 39.6;esophagus: 150.3;skin: 32.0 tonsil: 12.7 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB070422 Approved Group enriched 10 cerebral cortex: 6.2;colon: 1.4;rectum: 4.3 testis: 0.3 GOLGA7B bA451M19.3, bA459F3.4, C10orf132, C10orf133 ENSG00000155265 Golgin A7 family, member B 10 97850239-97871580 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046878 Uncertain Group enriched 7 cerebral cortex: 18.4;epididymis: 28.1;skin: 17.4 adrenal gland: 3.1 GPR162 A-2, GRCA ENSG00000250510 G protein-coupled receptor 162 12 6821545-6829972 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA055135 Supported Approved Microtubule organizing center Group enriched 6 cerebral cortex: 84.5;fallopian tube: 29.1 lung: 9.6 GPR22 ENSG00000172209 G protein-coupled receptor 22 7 107470018-107475659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 13 adrenal gland: 2.4;cerebral cortex: 9.5;cervix, uterine: 6.3;endometrium: 5.0;heart muscle: 11.9 smooth muscle: 0.5 GPR83 GPR72 ENSG00000123901 G protein-coupled receptor 83 11 94377311-94401419 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 adrenal gland: 1.0;cerebral cortex: 4.6;thyroid gland: 5.2 epididymis: 0.6 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007488 Uncertain Approved Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue: 0.6 GRIN3A GluN3A ENSG00000198785 Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A 9 101569353-101738580 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 cerebral cortex: 12.4;cervix, uterine: 2.5 seminal vesicle: 1.4 GSG1L2 ENSG00000214978 GSG1-like 2 17 9802386-9822071 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA059428 Uncertain Group enriched 14 cerebral cortex: 1.5;testis: 1.1 epididymis: 0.0 HAPLN4 BRAL2, KIAA1926 ENSG00000187664 Hyaluronan and proteoglycan link protein 4 19 19255641-19262796 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055856 Approved Group enriched 7 cerebral cortex: 8.5;duodenum: 15.7;small intestine: 21.7 cervix: 2.1 HCN2 BCNG-2, BCNG2, HAC-1 ENSG00000099822 Hyperpolarization activated cyclic nucleotide gated potassium channel 2 19 589893-617159 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 38.5;heart muscle: 8.1 testis: 3.4 HCN4 ENSG00000138622 Hyperpolarization activated cyclic nucleotide gated potassium channel 4 15 73319859-73369264 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 1.4;heart muscle: 1.9;testis: 6.7 adrenal gland: 0.5 HIPK4 FLJ32818 ENSG00000160396 Homeodomain interacting protein kinase 4 19 40379271-40390187 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027733 Uncertain Group enriched 22 cerebral cortex: 4.7;testis: 14.7 seminal vesicle: 0.4 HRK DP5 ENSG00000135116 Harakiri, BCL2 interacting protein 12 116856144-116881441 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025973 Uncertain Group enriched 9 cerebral cortex: 13.4;thyroid gland: 6.4 testis: 1.1 HS3ST5 3-OST-5 ENSG00000249853 Heparan sulfate (glucosamine) 3-O-sulfotransferase 5 6 114055586-114343045 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021823, HPA064677 Approved Group enriched 5 cerebral cortex: 6.2;seminal vesicle: 2.2;skeletal muscle: 1.3 adrenal gland: 0.6 HTR1A 5-HT1A, ADRB2RL1, ADRBRL1 ENSG00000178394 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 5 63960356-63962507 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA018073 Uncertain Group enriched 10 cerebral cortex: 1.9;ovary: 3.9 testis: 0.2 IGDCC3 HsT18880, PUNC ENSG00000174498 Immunoglobulin superfamily, DCC subclass, member 3 15 65327127-65378040 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015246 Approved Group enriched 5 cerebral cortex: 3.3;parathyroid gland: 14.4;placenta: 8.5;testis: 5.2 thyroid gland: 1.5 IGLON5 LOC402665 ENSG00000142549 IgLON family member 5 19 51311848-51330354 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041994 Approved Uncertain Nucleus Group enriched 7 adrenal gland: 2.3;cerebral cortex: 11.1;testis: 9.5 seminal vesicle: 1.1 ISLR2 KIAA1465 ENSG00000167178 Immunoglobulin superfamily containing leucine-rich repeat 2 15 74100311-74138540 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA012930, HPA067333 Uncertain Group enriched 5 cerebral cortex: 31.2;testis: 15.2 endometrium: 4.5 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium channel, voltage gated eag related subfamily H, member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Approved Nucleus
Mitochondria Group enriched 5 cerebral cortex: 24.3;fallopian tube: 7.1;parathyroid gland: 4.9 adrenal gland: 2.2 KCNIP2 KCHIP2 ENSG00000120049 Kv channel interacting protein 2 10 101825974-101843920 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066717 Uncertain Vesicles Group enriched 7 adipose tissue: 238.4;cerebral cortex: 81.6;heart muscle: 150.4 testis: 23.9 KCNJ10 Kir1.2, Kir4.1 ENSG00000177807 Potassium channel, inwardly rectifying subfamily J, member 10 1 160037467-160070248 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 120.1;kidney: 27.8 spleen: 13.3 KCNJ4 HIR, hIRK2, HRK1, IRK3, Kir2.3 ENSG00000168135 Potassium channel, inwardly rectifying subfamily J, member 4 22 38426327-38455199 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 25 cerebral cortex: 41.0;heart muscle: 11.7 gallbladder: 1.0 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KCTD16 KIAA1317 ENSG00000183775 Potassium channel tetramerization domain containing 16 5 144170832-144485686 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044590, HPA050154 Approved Approved Nuclear speckles Group enriched 7 cerebral cortex: 12.3;testis: 3.0 lung: 1.1 KCTD4 bA321C24.3 ENSG00000180332 Potassium channel tetramerization domain containing 4 13 45192853-45194717 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040734 Uncertain Approved Microtubule organizing center Group enriched 10 cerebral cortex: 17.7;skin: 3.7 gallbladder: 1.1 KHDRBS3 Etle, etoile, SALP, SLM-2, SLM2, T-STAR ENSG00000131773 KH domain containing, RNA binding, signal transduction associated 3 8 135457457-135656722 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000275, HPA000500, HPA000981 Supported Supported Nucleoplasm Group enriched 7 cerebral cortex: 89.3;testis: 284.7 epididymis: 27.4 KIAA1549L C11orf41, C11orf69, G2, MGC34830 ENSG00000110427 KIAA1549-like 11 33542072-33674102 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051594 Approved Nucleoplasm Group enriched 40 cerebral cortex: 35.0;parathyroid gland: 143.5 skin: 2.2 KIF6 C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317 ENSG00000164627 Kinesin family member 6 6 39329990-39725405 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038811, HPA058624 Supported Approved Centrosome Group enriched 6 cerebral cortex: 7.1;fallopian tube: 6.0;testis: 9.7 lung: 1.2 KLHL32 BKLHD5, KIAA1900 ENSG00000186231 Kelch-like family member 32 6 96924620-97140754 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039150 Approved Group enriched 6 cerebral cortex: 25.4;fallopian tube: 10.2 testis: 3.1 KLK6 Bssp, Klk7, neurosin, PRSS18, PRSS9 ENSG00000167755 Kallikrein-related peptidase 6 19 50958631-50969673 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051837 Supported Nucleoplasm
Nuclear membrane
Cytokinetic bridge Group enriched 5 cerebral cortex: 79.0;esophagus: 63.2;fallopian tube: 44.3;tonsil: 32.5 kidney: 10.1 KLRC2 CD159c, NKG2-C ENSG00000205809 Killer cell lectin-like receptor subfamily C, member 2 12 10426854-10442300 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA058052 Approved Plasma membrane Group enriched 6 cerebral cortex: 17.4;spleen: 8.3 stomach: 2.0 LGI3 ENSG00000168481 Leucine-rich repeat LGI family, member 3 8 22146825-22157084 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA024826 Approved Cytosol Group enriched 7 cerebral cortex: 76.2;lung: 23.9;skin: 17.4;thyroid gland: 21.5 esophagus: 5.2 LMTK3 KIAA1883, LMR3, PPP1R101, TYKLM3 ENSG00000142235 Lemur tyrosine kinase 3 19 48485271-48513189 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040203 Approved Nucleoplasm
Cell Junctions Group enriched 5 cerebral cortex: 20.4;parathyroid gland: 4.8 duodenum: 2.3 LRP8 APOER2, HSZ75190, LRP-8, MCI1 ENSG00000157193 Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor 1 53242364-53328070 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 25.2;testis: 47.4;thyroid gland: 87.3 appendix: 7.9 LRRC3B LRP15 ENSG00000179796 Leucine rich repeat containing 3B 3 26622806-26710776 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015568 Approved Group enriched 7 cerebral cortex: 19.2;skeletal muscle: 3.9;testis: 13.0 ovary: 1.6 LYPD1 LYPDC1, MGC29643 ENSG00000150551 LY6/PLAUR domain containing 1 2 132644853-132671579 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 17 cerebral cortex: 27.3;fallopian tube: 125.8 salivary gland: 4.5 MAP6D1 FLJ12748, SL21 ENSG00000180834 MAP6 domain containing 1 3 183815876-183825594 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037991 Approved Cytosol Group enriched 7 cerebral cortex: 43.2;skeletal muscle: 11.0 skin: 4.1 MC4R ENSG00000166603 Melanocortin 4 receptor 18 60371110-60372775 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016719 Uncertain Group enriched 10 cerebral cortex: 3.0;fallopian tube: 5.0 epididymis: 0.4 MCF2 ARHGEF21, DBL ENSG00000101977 MCF.2 cell line derived transforming sequence X 139581770-139708227 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 adrenal gland: 38.5;cerebral cortex: 8.7;epididymis: 14.7;ovary: 12.8;seminal vesicle: 23.7;testis: 34.4 prostate: 2.1 MCF2L2 ARHGEF22, KIAA0861 ENSG00000053524 MCF.2 cell line derived transforming sequence-like 2 3 183178043-183428778 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038946, HPA038947 Uncertain Approved Plasma membrane
Cytosol Group enriched 8 adrenal gland: 10.3;cerebral cortex: 17.1;parathyroid gland: 7.4;spleen: 3.5;testis: 4.6 prostate: 1.0 MCHR2 GPR145, MCH2, MCH2R, SLT ENSG00000152034 Melanin-concentrating hormone receptor 2 6 99919910-99994247 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 53 cerebral cortex: 8.6;testis: 6.2 colon: 0.1 MDGA2 MAMDC1 ENSG00000139915 MAM domain containing glycosylphosphatidylinositol anchor 2 14 46839629-47674954 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003084 Uncertain Group enriched 15 cerebral cortex: 6.3;testis: 6.9 skin: 0.4 MEGF11 DKFZp434L121, KIAA1781 ENSG00000157890 Multiple EGF-like-domains 11 15 65895079-66253747 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA017982 Uncertain Group enriched 6 cerebral cortex: 13.0;fallopian tube: 12.2 testis: 1.9 MGAT4C HGNT-IV-H ENSG00000182050 MGAT4 family, member C 12 85955666-86838904 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 cerebral cortex: 11.9;epididymis: 13.6;testis: 11.1;thyroid gland: 31.8 adrenal gland: 3.3 MMD2 PAQR10 ENSG00000136297 Monocyte to macrophage differentiation-associated 2 7 4905989-4959213 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 82 cerebral cortex: 41.3;testis: 12.4 adrenal gland: 0.3 MSANTD1 C4orf44, LOC345222 ENSG00000188981 Myb/SANT-like DNA-binding domain containing 1 4 3244369-3271738 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 7 cerebral cortex: 1.9;testis: 2.5 epididymis: 0.3 NAT16 C7orf52, FLJ39237 ENSG00000167011 N-acetyltransferase 16 (GCN5-related, putative) 7 101170493-101180276 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA021918 Uncertain Uncertain Nucleus Group enriched 8 cerebral cortex: 5.1;thyroid gland: 3.0 pancreas: 0.5 NAT8L FLJ37478, Hcml3 ENSG00000185818 N-acetyltransferase 8-like (GCN5-related, putative) 4 2059512-2069089 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040677 Supported Mitochondria Group enriched 7 adipose tissue: 48.6;cerebral cortex: 65.1;testis: 19.0 kidney: 6.7 NEU4 ENSG00000204099 Sialidase 4 2 241808825-241817413 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037394, HPA037395 Uncertain Group enriched 7 bone marrow: 2.4;cerebral cortex: 6.4;colon: 8.5;duodenum: 5.7;liver: 4.1;rectum: 3.9;small intestine: 5.4 gallbladder: 0.8 NGB ENSG00000165553 Neuroglobin 14 77265483-77271312 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042615, HPA058596 Supported Group enriched 5 adrenal gland: 10.2;cerebral cortex: 4.8;fallopian tube: 2.1 pancreas: 1.0 NKX6-2 GTX, NKX6.1, NKX6B ENSG00000148826 NK6 homeobox 2 10 132783179-132786052 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 26 cerebral cortex: 15.8;stomach: 17.1 testis: 0.6 NNAT Peg5 ENSG00000053438 Neuronatin 20 37521215-37523693 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 cerebral cortex: 158.1;placenta: 148.0 adipose tissue: 28.1 NOG SYM1, SYNS1 ENSG00000183691 Noggin 17 56593699-56595590 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA061318 Approved Group enriched 5 cerebral cortex: 7.3;placenta: 15.8 lymph node: 2.2 NOL4 CT125, HRIHFB2255, NOLP ENSG00000101746 Nucleolar protein 4 18 33851100-34224952 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA046740 Supported Nucleus Group enriched 7 cerebral cortex: 16.0;testis: 22.7 thyroid gland: 2.9 NPAS1 bHLHe11, MOP5, PASD5 ENSG00000130751 Neuronal PAS domain protein 1 19 47019820-47045775 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043364, HPA072259 Approved Approved Nucleoplasm Group enriched 5 cerebral cortex: 3.9;skin: 4.4;spleen: 1.9;stomach: 2.7 lymph node: 0.6 NPY PYY4 ENSG00000122585 Neuropeptide Y 7 24284163-24291865 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009978, CAB016733, CAB034368, HPA044572, HPA056798 Supported Supported Validated Golgi apparatus Group enriched 16 adrenal gland: 154.2;cerebral cortex: 212.3;prostate: 448.9 appendix: 16.6 NTNG2 KIAA1857, Lmnt2, NTNG1 ENSG00000196358 Netrin G2 9 132161676-132244534 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071290 Approved Group enriched 5 bone marrow: 26.5;cerebral cortex: 18.5;parathyroid gland: 16.0;prostate: 8.6 spleen: 3.2 NWD1 ENSG00000188039 NACHT and WD repeat domain containing 1 19 16719976-16817963 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 cerebral cortex: 1.9;fallopian tube: 7.6;prostate: 5.8;seminal vesicle: 1.6 lung: 0.6 NXPH2 NPH2 ENSG00000144227 Neurexophilin 2 2 138670772-138780348 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034759 Approved Group enriched 9 cerebral cortex: 5.7;kidney: 5.0;ovary: 13.9 endometrium: 0.9 OLR1 CLEC8A, LOX-1, SCARE1 ENSG00000173391 Oxidized low density lipoprotein (lectin-like) receptor 1 12 10158301-10172138 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050798 Supported Nucleoplasm
Vesicles
Plasma membrane Group enriched 6 appendix: 42.1;cerebral cortex: 32.8;lung: 146.2;placenta: 159.6 bone marrow: 15.8 OPRK1 KOR, OPRK ENSG00000082556 Opioid receptor, kappa 1 8 53225716-53251697 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB022595 Uncertain Group enriched 7 cerebral cortex: 3.6;prostate: 3.2;testis: 1.8 skeletal muscle: 0.3 PABPC1L2A RBM32A ENSG00000186288 Poly(A) binding protein, cytoplasmic 1-like 2A X 73077276-73079512 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041573 Approved Group enriched 5 adrenal gland: 2.0;cerebral cortex: 6.7;prostate: 3.7;testis: 2.8 epididymis: 0.7 PABPC1L2B RBM32B ENSG00000184388 Poly(A) binding protein, cytoplasmic 1-like 2B X 73003517-73005713 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041573 Approved Group enriched 5 cerebral cortex: 8.8;prostate: 4.5 testis: 1.2 PAPL ENSG00000183760 Iron/zinc purple acid phosphatase-like protein 19 39083913-39111493 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042005, HPA042613 Uncertain Group enriched 6 cerebral cortex: 1.8;skin: 6.9;tonsil: 2.5 epididymis: 0.6 PAX6 AN, AN2, D11S812E, WAGR ENSG00000007372 Paired box 6 11 31784792-31817961 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030775, CAB034143 Supported Validated Nucleoplasm Group enriched 6 cerebral cortex: 24.4;stomach: 12.1 testis: 2.9 PAX7 Hup1 ENSG00000009709 Paired box 7 1 18631006-18748866 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 cerebral cortex: 1.4;skeletal muscle: 2.2 testis: 0.2 PCDH10 KIAA1400, OL-PCDH ENSG00000138650 Protocadherin 10 4 133149315-133208606 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA011220, HPA073462 Approved Approved Nucleus
Golgi apparatus
Vesicles Group enriched 5 cerebral cortex: 62.2;placenta: 36.4;prostate: 17.0;seminal vesicle: 24.4 adrenal gland: 6.9 PEX5L PEX5R, PXR2, TRIP8b ENSG00000114757 Peroxisomal biogenesis factor 5-like 3 179794958-180037053 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058026 Approved Group enriched 9 cerebral cortex: 67.7;parathyroid gland: 93.0 testis: 8.8 PHF24 KIAA1045 ENSG00000122733 PHD finger protein 24 9 34957608-34982544 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020974 Approved Group enriched 36 cerebral cortex: 58.7;testis: 25.8 skin: 1.1 PLEKHB1 KPL1, PHR1, PHRET1 ENSG00000021300 Pleckstrin homology domain containing, family B (evectins) member 1 11 73646178-73662819 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 496.1;parathyroid gland: 145.9 thyroid gland: 48.2 PLPPR1 FLJ20300, LPPR1, MGC26189, PRG-3 ENSG00000148123 Phospholipid phosphatase related 1 9 101028709-101325135 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014760, HPA014968, HPA014979 Supported Approved Nucleoplasm Group enriched 6 cerebral cortex: 23.9;kidney: 15.7 epididymis: 3.2 PLPPR5 LPPR5, PAP2, PAP2D, PRG5 ENSG00000117598 Phospholipid phosphatase related 5 1 98890245-99005032 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018072 Uncertain Approved Nucleus
Plasma membrane
Centrosome Group enriched 11 cerebral cortex: 12.0;testis: 4.0 adrenal gland: 0.7 PNMA3 MA3, MA5, MGC132756, MGC132758 ENSG00000183837 Paraneoplastic Ma antigen 3 X 153056409-153060467 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA047920 Approved Group enriched 13 cerebral cortex: 15.4;epididymis: 44.8;testis: 12.3 fallopian tube: 1.8 PNMA5 KIAA1934 ENSG00000198883 Paraneoplastic Ma antigen family member 5 X 152988824-152994127 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044690 Supported Group enriched 20 cerebral cortex: 8.1;testis: 16.2 spleen: 0.6 POPDC3 bA355M14.1, MGC22671, POP3 ENSG00000132429 Popeye domain containing 3 6 105158280-105179995 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA012514 Uncertain Approved Nucleoli
Cytosol Group enriched 6 cerebral cortex: 8.8;heart muscle: 18.4;skeletal muscle: 41.8;testis: 9.7 epididymis: 3.4 POU3F3 BRN1, OTF8 ENSG00000198914 POU class 3 homeobox 3 2 104855511-104860471 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA052792, HPA056039, HPA067151 Supported Supported Nucleus Group enriched 51 cerebral cortex: 36.6;epididymis: 34.9;kidney: 28.3;seminal vesicle: 17.2 skin: 0.5 PPFIA3 KIAA0654, LPNA3, MGC126567, MGC126569 ENSG00000177380 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 19 49119389-49151026 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043567, HPA050340 Supported Uncertain Nucleoli fibrillar center
Vesicles Group enriched 5 cerebral cortex: 21.6;skin: 20.2 parathyroid gland: 3.9 PPM1E CaMKP-N, KIAA1072, POPX1, PP2CH ENSG00000175175 Protein phosphatase, Mg2+/Mn2+ dependent, 1E 17 58755869-58985176 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018462, HPA019263 Approved Supported Nucleus
Nucleoli Group enriched 5 adrenal gland: 7.3;cerebral cortex: 20.5;testis: 12.1 fallopian tube: 2.4 PPP1R17 C7orf16, GSBS ENSG00000106341 Protein phosphatase 1, regulatory subunit 17 7 31686715-31708455 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047819 Supported Group enriched 5 adrenal gland: 4.9;cerebral cortex: 2.6;testis: 1.1 lung: 0.5 PRLHR GPR10, PrRPR ENSG00000119973 Prolactin releasing hormone receptor 10 118589989-118595699 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA039361 Supported Group enriched 7 adrenal gland: 6.5;cerebral cortex: 3.5;endometrium: 3.9;smooth muscle: 5.4 seminal vesicle: 0.7 PTCHD2 DISP3, KIAA1337 ENSG00000204624 Patched domain containing 2 1 11479166-11537584 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA054579 Uncertain Uncertain Nucleoplasm
Cytosol Group enriched 14 cerebral cortex: 8.7;testis: 4.3 adrenal gland: 0.4 PTPRT KIAA0283, RPTPrho ENSG00000196090 Protein tyrosine phosphatase, receptor type, T 20 42072752-43189970 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017336, CAB069423 Approved Group enriched 5 cerebral cortex: 24.4;fallopian tube: 17.2 placenta: 3.9 RAB6B ENSG00000154917 RAB6B, member RAS oncogene family 3 133824239-133895836 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017713, HPA059131 Uncertain Approved Golgi apparatus Group enriched 6 cerebral cortex: 211.9;parathyroid gland: 75.7 fallopian tube: 25.9 RASGEF1C FLJ35841 ENSG00000146090 RasGEF domain family, member 1C 5 180100791-180209153 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028242 Uncertain Approved Mitochondria Group enriched 8 cerebral cortex: 16.5;testis: 6.1 seminal vesicle: 1.3 RASGRF1 CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187 ENSG00000058335 Ras protein-specific guanine nucleotide-releasing factor 1 15 78959947-79090773 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010413, HPA041965 Approved Supported Golgi apparatus Group enriched 14 cerebral cortex: 30.6;lung: 11.7 lymph node: 1.5 RFX4 ENSG00000111783 Regulatory factor X, 4 (influences HLA class II expression) 12 106582907-106762803 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050527 Supported Approved Nucleus Group enriched 184 cerebral cortex: 30.9;testis: 135.3 prostate: 0.4 RGS7 ENSG00000182901 Regulator of G-protein signaling 7 1 240775514-241357230 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000688, CAB017561 Supported Approved Nucleus Group enriched 8 adrenal gland: 10.8;cerebral cortex: 47.0;testis: 13.4 stomach: 2.9 RGS8 MGC119067, MGC119068, MGC119069 ENSG00000135824 Regulator of G-protein signaling 8 1 182641816-182684576 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 cerebral cortex: 5.3;testis: 4.9;thyroid gland: 11.2 adrenal gland: 1.3 RP11-277P12.6 ENSG00000255641 12 10412312-10436001 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA062570 Uncertain Group enriched 7 cerebral cortex: 8.2;spleen: 6.2 bone marrow: 1.0 RS1 RS, XLRS1 ENSG00000102104 Retinoschisin 1 X 18639910-18672109 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059546 Supported Group enriched 8 cerebral cortex: 1.1;lung: 1.7 thyroid gland: 0.1 RTBDN FLJ36353 ENSG00000132026 Retbindin 19 12825478-12835428 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052511 Approved Endoplasmic reticulum Group enriched 6 adrenal gland: 4.6;cerebral cortex: 14.7;testis: 3.5 stomach: 1.2 RTN4RL2 NgR2, NGRH1 ENSG00000186907 Reticulon 4 receptor-like 2 11 57460549-57477534 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 48.9;thyroid gland: 36.1 liver: 6.6 SATB2 FLJ21474, KIAA1034 ENSG00000119042 SATB homeobox 2 2 199269500-199471266 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231 Supported Supported Nucleoplasm Group enriched 6 cerebral cortex: 22.8;colon: 37.7;rectum: 48.3 small intestine: 6.5 SEPT4 ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2 ENSG00000108387 Septin 4 17 58520250-58540818 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006855, HPA021587, HPA022905 Supported Supported Nucleoplasm Group enriched 5 adrenal gland: 218.2;cerebral cortex: 288.7;spleen: 57.8 adipose tissue: 36.8 SH2D5 ENSG00000189410 SH2 domain containing 5 1 20719732-20732837 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030182 Supported Cytosol Group enriched 7 cerebral cortex: 16.6;placenta: 5.1;testis: 10.5 thyroid gland: 1.5 SH3GL3 CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13 ENSG00000140600 SH3-domain GRB2-like 3 15 83447228-83618743 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039381, HPA077877 Supported Approved Cytosol Group enriched 12 cerebral cortex: 30.0;testis: 38.3 lung: 2.9 SH3TC2 CMT4C, KIAA1985 ENSG00000169247 SH3 domain and tetratricopeptide repeats 2 5 148923639-149063163 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037683, HPA037684 Uncertain Approved Nucleoplasm
Cytosol Group enriched 6 cerebral cortex: 3.0;placenta: 2.8;testis: 8.7 heart muscle: 0.8 SHC4 RaLP ENSG00000185634 SHC (Src homology 2 domain containing) family, member 4 15 48823735-48963444 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA074146 Approved Cytosol Group enriched 7 cerebral cortex: 13.2;testis: 20.4 gallbladder: 2.3 SHD ENSG00000105251 Src homology 2 domain containing transforming protein D 19 4278601-4290724 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017955 Approved Uncertain Microtubule organizing center
Cytosol Group enriched 15 cerebral cortex: 22.2;heart muscle: 4.5 appendix: 0.9 SHISA4 C1orf40, hShisa4, TMEM58 ENSG00000198892 Shisa family member 4 1 201888680-201892306 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA061273 Uncertain Group enriched 5 adrenal gland: 23.6;cerebral cortex: 45.5;skeletal muscle: 94.5 heart muscle: 10.8 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041505, HPA044066 Supported Uncertain Intermediate filaments Group enriched 6 cerebral cortex: 16.2;skin: 8.9;testis: 36.8 epididymis: 3.7 SLC30A3 ZNT3 ENSG00000115194 Solute carrier family 30 (zinc transporter), member 3 2 27253684-27275817 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060505, HPA067637 Approved Approved Nucleus
Nucleoli
Vesicles
Cytosol Group enriched 14 cerebral cortex: 36.7;epididymis: 65.2;testis: 43.6 heart muscle: 3.4 SLC4A3 AE3, SLC2C ENSG00000114923 Solute carrier family 4 (anion exchanger), member 3 2 219627327-219641980 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA063498 Approved Nucleoplasm Group enriched 6 cerebral cortex: 30.1;heart muscle: 125.7;ovary: 47.6 testis: 10.9 SLC5A11 KST1, SGLT6, SMIT2 ENSG00000158865 Solute carrier family 5 (sodium/inositol cotransporter), member 11 16 24845841-24911628 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035331 Uncertain Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 10.5;duodenum: 6.8;kidney: 6.0;small intestine: 15.5 breast: 1.7 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supported Uncertain Mitochondria Group enriched 5 cerebral cortex: 119.7;liver: 50.3 parathyroid gland: 15.7 SLC8A3 NCX3 ENSG00000100678 Solute carrier family 8 (sodium/calcium exchanger), member 3 14 70044217-70189070 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 16.3;skeletal muscle: 6.1 adrenal gland: 1.7 SOHLH1 bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2 ENSG00000165643 Spermatogenesis and oogenesis specific basic helix-loop-helix 1 9 135693407-135699528 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA059439 Approved Nuclear speckles Group enriched 27 cerebral cortex: 6.4;testis: 13.4 skin: 0.3 SOX1 ENSG00000182968 SRY (sex determining region Y)-box 1 13 112067647-112070488 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 cerebral cortex: 3.6;testis: 1.5 skin: 0.3 SOX21 SOX25 ENSG00000125285 SRY (sex determining region Y)-box 21 13 94709622-94712399 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA064084 Approved Nucleus Group enriched 6 cerebral cortex: 18.0;esophagus: 6.9;skin: 19.4;stomach: 33.9 tonsil: 3.2 SPHKAP SKIP ENSG00000153820 SPHK1 interactor, AKAP domain containing 2 227979950-228181645 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042499, HPA048168 Supported Group enriched 7 cerebral cortex: 19.5;heart muscle: 20.3 ovary: 2.7 SRPK2 SFRSK2 ENSG00000135250 SRSF protein kinase 2 7 105110704-105399308 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015522, HPA020876 Approved Supported Nucleus
Cytosol Group enriched 5 cerebral cortex: 108.6;testis: 196.7 endometrium: 29.8 SRRM3 FLJ37078 ENSG00000177679 Serine/arginine repetitive matrix 3 7 76201900-76287288 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA019337 Uncertain Approved Plasma membrane
Intermediate filaments
Microtubules Group enriched 10 adrenal gland: 2.7;cerebral cortex: 8.5;testis: 1.8 stomach: 0.4 SRSF12 SFRS13B, SFRS19, SRrp35 ENSG00000154548 Serine/arginine-rich splicing factor 12 6 89095959-89118081 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA049782 Approved Group enriched 6 cerebral cortex: 6.9;testis: 20.9 thyroid gland: 2.2 STAC2 24b2 ENSG00000141750 SH3 and cysteine rich domain 2 17 39210536-39225872 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017288 Approved Nucleoplasm
Vesicles Group enriched 6 breast: 31.7;cerebral cortex: 30.2;epididymis: 14.8;seminal vesicle: 35.5 skin: 4.5 TCEAL5 WEX4 ENSG00000204065 Transcription elongation factor A (SII)-like 5 X 103273691-103276872 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045564, HPA058982, HPA072199 Uncertain Uncertain Nucleoplasm
Cytosol Group enriched 7 cerebral cortex: 82.7;testis: 82.5 adrenal gland: 11.9 TCEAL6 WEX2 ENSG00000204071 Transcription elongation factor A (SII)-like 6 X 102140476-102142970 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045564, HPA058982 Uncertain Group enriched 6 adrenal gland: 15.0;cerebral cortex: 65.3;testis: 35.6 endometrium: 6.2 TMEM130 DKFZp761L1417, FLJ42643 ENSG00000166448 Transmembrane protein 130 7 98846488-98870771 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA012928 Uncertain Supported Golgi apparatus Group enriched 9 adrenal gland: 49.3;cerebral cortex: 183.7;testis: 70.8 epididymis: 11.5 TMEM132E DFNB99 ENSG00000181291 Transmembrane protein 132E 17 34580749-34639318 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA070608 Approved Group enriched 5 cerebral cortex: 4.8;duodenum: 1.7;kidney: 3.2;small intestine: 1.1;testis: 1.5 cervix: 0.4 TMEM155 FLJ30834 ENSG00000164112 Transmembrane protein 155 4 121758933-121765427 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 cerebral cortex: 27.7;placenta: 5.7 lymph node: 3.0 TMEM233 IFITMD2 ENSG00000224982 Transmembrane protein 233 12 119593459-119643066 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA047506 Uncertain Group enriched 5 cerebral cortex: 16.3;skeletal muscle: 11.5;thyroid gland: 21.4 parathyroid gland: 3.1 TUBA8 TUBAL2 ENSG00000183785 Tubulin, alpha 8 22 18110331-18146554 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043684, CAB046031, HPA063394 Approved Supported Microtubules Group enriched 6 cerebral cortex: 28.7;heart muscle: 85.0;skeletal muscle: 121.8;testis: 47.4 thyroid gland: 11.2 UNC13C DKFZp547H074, Munc13-3 ENSG00000137766 Unc-13 homolog C (C. elegans) 15 54012904-54633414 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041516 Uncertain Group enriched 15 cerebral cortex: 17.4;testis: 15.2 thyroid gland: 1.1 WASF1 KIAA0269, SCAR1, WAVE, WAVE1 ENSG00000112290 WAS protein family, member 1 6 110099819-110180004 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004105, CAB022161 Approved Approved Group enriched 5 cerebral cortex: 139.4;testis: 149.1 ovary: 27.6 ZFR2 KIAA1086 ENSG00000105278 Zinc finger RNA binding protein 2 19 3804024-3869032 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043275, HPA055678 Uncertain Uncertain Nucleoplasm Group enriched 9 adrenal gland: 3.8;cerebral cortex: 12.7;testis: 19.0 fallopian tube: 1.3 ZIC5 ENSG00000139800 Zic family member 5 13 99962964-99971909 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA074045 Uncertain Nucleoplasm
Vesicles Group enriched 45 cerebral cortex: 2.3;testis: 6.6 adipose tissue: 0.0 ZIM2 ZNF656 ENSG00000269699 Zinc finger, imprinted 2 19 56774552-56840729 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA071856 Approved Nuclear speckles
Cytosol Group enriched 6 adrenal gland: 5.8;cerebral cortex: 5.1;ovary: 10.0;placenta: 6.8;testis: 7.8 endometrium: 1.1 ZMAT4 FLJ13842 ENSG00000165061 Zinc finger, matrin-type 4 8 40530590-40897833 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069813, HPA071585 Supported Supported Nucleus
Nucleoli Group enriched 8 cerebral cortex: 10.1;thyroid gland: 27.5 testis: 2.3 ZNF488 FLJ32104 ENSG00000265763 Zinc finger protein 488 10 47365496-47384273 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA035957, HPA035958, HPA044867 Uncertain Supported Nucleoplasm
Cytosol Group enriched 7 cerebral cortex: 19.1;duodenum: 23.2;placenta: 4.7;small intestine: 12.4 skin: 2.0